{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:14:00Z","timestamp":1789755240509,"version":"4.0.1"},"reference-count":38,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,10,24]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>An in vitro model shows that hemolysis could be due to the presence of a subclinical PNH clone causing a negative C3b\/d DAT. Changes to decay-accelerating factor and membrane inhibitor of reactive lysis may lead to overt hemolysis after minor mismatched transfusions.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017008805","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:50:14Z","timestamp":1507769414000},"page":"1977-1982","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions"],"prefix":"10.1182","volume":"1","author":[{"given":"Priyanka","family":"Pandey","sequence":"first","affiliation":[{"name":"Diagnostic Laboratories and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem Q.","family":"Anani","sequence":"additional","affiliation":[{"name":"Diagnostic Laboratories and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome L.","family":"Gottschall","sequence":"additional","affiliation":[{"name":"Diagnostic Laboratories and"},{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-1679","authenticated-orcid":false,"given":"Gregory A.","family":"Denomme","sequence":"additional","affiliation":[{"name":"Diagnostic Laboratories and"},{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"issue":"8","key":"2019111611294689800_B1","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1537-2995.2010.02642.x","article-title":"Practices associated with ABO-incompatible platelet transfusions: a BEST Collaborative international survey","volume":"50","author":"Lozano","year":"2010","journal-title":"Transfusion"},{"issue":"8","key":"2019111611294689800_B2","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/trf.13077","article-title":"Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions","volume":"55","author":"Dunbar","year":"2015","journal-title":"Transfusion"},{"issue":"1","key":"2019111611294689800_B3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1537-2995.1998.38198141498.x","article-title":"Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets","volume":"38","author":"Mair","year":"1998","journal-title":"Transfusion"},{"issue":"2","key":"2019111611294689800_B4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ajcp\/111.2.202","article-title":"Intravascular hemolysis secondary to ABO incompatible platelet products. An underrecognized transfusion reaction","volume":"111","author":"McManigal","year":"1999","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"2019111611294689800_B5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1537-2995.2000.40080902.x","article-title":"Acute intravascular hemolysis secondaryto out-of-group platelet transfusion","volume":"40","author":"Larsson","year":"2000","journal-title":"Transfusion"},{"issue":"10","key":"2019111611294689800_B6","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1537-2995.2012.03574.x","article-title":"ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions","volume":"52","author":"Karafin","year":"2012","journal-title":"Transfusion"},{"issue":"5","key":"2019111611294689800_B7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-3148.2006.00684.x","article-title":"Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction","volume":"16","author":"Sadani","year":"2006","journal-title":"Transfus Med"},{"issue":"6","key":"2019111611294689800_B8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1537-2995.2001.41060790.x","article-title":"Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery","volume":"41","author":"Blumberg","year":"2001","journal-title":"Transfusion"},{"issue":"1","key":"2019111611294689800_B9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1423-0410.2010.01464.x","article-title":"An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients","volume":"101","author":"Refaai","year":"2011","journal-title":"Vox Sang"},{"issue":"8","key":"2019111611294689800_B10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1537-2995.1989.29890020439.x","article-title":"Paroxysmal nocturnal hemoglobinuria and the transfusion of washed red cells. A myth revisited","volume":"29","author":"Brecher","year":"1989","journal-title":"Transfusion"},{"issue":"12","key":"2019111611294689800_B11","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111611294689800_B12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2141.1989.tb00260.x","article-title":"Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor)","volume":"73","author":"Merry","year":"1989","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111611294689800_B13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood.V74.1.437.437","article-title":"The Inab phenotype: characterization of the membrane protein and complement regulatory defect","volume":"74","author":"Telen","year":"1989","journal-title":"Blood"},{"issue":"22","key":"2019111611294689800_B14","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood-2015-06-640995","article-title":"Complement in hemolytic anemia","volume":"126","author":"Brodsky","year":"2015","journal-title":"Blood"},{"key":"2019111611294689800_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2016.06.001","article-title":"Overview of laboratory testing and clinical presentations of complement deficiencies and dysregulation","volume":"77","author":"Frazer-Abel","year":"2016","journal-title":"Adv Clin Chem"},{"issue":"1","key":"2019111611294689800_B16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transci.2009.10.013","article-title":"ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies","volume":"42","author":"Josephson","year":"2010","journal-title":"Transfus Apheresis Sci"},{"issue":"1","key":"2019111611294689800_B17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1537-2995.2010.02759.x","article-title":"A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies","volume":"51","author":"Quillen","year":"2011","journal-title":"Transfusion"},{"issue":"10","key":"2019111611294689800_B18","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1537-2995.2012.03596.x","article-title":"How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products","volume":"52","author":"Fontaine","year":"2012","journal-title":"Transfusion"},{"issue":"Suppl 2","key":"2019111611294689800_B19","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1111\/trf.13147","article-title":"Pathogenesis and mechanisms of antibody-mediated hemolysis","volume":"55","author":"Flegel","year":"2015","journal-title":"Transfusion"},{"key":"2019111611294689800_B20","volume-title":"Judd\u2019s Methods in Immunohematology","author":"Judd","year":"2008"},{"issue":"12","key":"2019111611294689800_B21","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood.V77.12.2764.2764","article-title":"Induction of the paroxysmal nocturnal hemoglobinuria phenotype in normal human erythrocytes: effects of 2-aminoethylisothiouronium bromide on membrane proteins that regulate complement","volume":"77","author":"Ezzell","year":"1991","journal-title":"Blood"},{"issue":"5102","key":"2019111611294689800_B22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/215747a0","article-title":"Immune lysis of AET-treated normal red cells (PNH-like cells)","volume":"215","author":"Sirchia","year":"1967","journal-title":"Nature"},{"issue":"8","key":"2019111611294689800_B23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jcp.24.8.677","article-title":"Electron microscope study of PNH red cells and AET-treated normal red cells (PNH-like cells)","volume":"24","author":"Lewis","year":"1971","journal-title":"J Clin Pathol"},{"issue":"6","key":"2019111611294689800_B24","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1172\/JCI111927","article-title":"Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes","volume":"75","author":"Parker","year":"1985","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111611294689800_B25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/icb.1995.11","article-title":"Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells","volume":"73","author":"Yuan","year":"1995","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"2019111611294689800_B26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bcmd.2013.12.003","article-title":"Direct antiglobulin (\u201cCoombs\u201d) test-negative autoimmune hemolytic anemia: a review","volume":"52","author":"Segel","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"2019111611294689800_B27","article-title":"The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy [published online ahead of print 14 August 2017]","author":"Bat","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111611294689800_B28","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.174.5.3059","article-title":"Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1","volume":"174","author":"Craig","year":"2005","journal-title":"J Immunol"},{"issue":"9","key":"2019111611294689800_B29","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1537-2995.2011.03535.x","article-title":"Outpatient transfusions and occurrence of serious noninfectious transfusion-related complications among US elderly, 2007-2008: utility of large administrative databases in blood safety research","volume":"52","author":"Menis","year":"2012","journal-title":"Transfusion"},{"issue":"13","key":"2019111611294689800_B30","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"2019111611294689800_B31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.tp.0000167758.63247.f4","article-title":"Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children","volume":"80","author":"Lapierre","year":"2005","journal-title":"Transplantation"},{"issue":"3","key":"2019111611294689800_B32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/trf.13376","article-title":"Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood","volume":"56","author":"Pai","year":"2016","journal-title":"Transfusion"},{"issue":"3","key":"2019111611294689800_B33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/vox.12354","article-title":"ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion","volume":"110","author":"Zaffuto","year":"2016","journal-title":"Vox Sang"},{"issue":"10","key":"2019111611294689800_B34","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/trf.14255","article-title":"An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study","volume":"57","author":"Zeller","year":"2017","journal-title":"Transfusion"},{"issue":"10","key":"2019111611294689800_B35","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1537-2995.2008.01814.x","article-title":"Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets","volume":"48","author":"Cooling","year":"2008","journal-title":"Transfusion"},{"issue":"6","key":"2019111611294689800_B36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5858\/2007-131-909-TOPCAP","article-title":"Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories","volume":"131","author":"Fung","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2019111611294689800_B37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1537-2995.2004.03290.x","article-title":"Significant numbers of apheresis-derived group O platelet units have \u201chigh-titer\u201d anti-A\/A,B: implications for transfusion policy","volume":"44","author":"Josephson","year":"2004","journal-title":"Transfusion"},{"issue":"5","key":"2019111611294689800_B38","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1537-2995.2010.02897.x","article-title":"A comparison of washed and volume-reduced platelets with respect to platelet activation, aggregation, and plasma protein removal","volume":"51","author":"Veeraputhiran","year":"2011","journal-title":"Transfusion"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/23\/1977\/878817\/advances008805.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/23\/1977\/878817\/advances008805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T09:24:27Z","timestamp":1659605067000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/23\/1977\/15704\/Potential-impact-of-complement-regulator"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":38,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,10,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017008805","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,11]]}}}